Renalytix Market Cap

Renalytix has a market cap or net worth of 18.03 million as of February 13, 2026. Its market cap has decreased by -48.16% in one year.

Market Cap

18.03M

Enterprise Value

21.38M

Revenue

2.19M

Ranking

n/a

PE Ratio

n/a

Stock Price

4.20

Market Cap Chart

Since November 6, 2018, Renalytix's market cap has decreased from 64.58M to 18.03M, a decrease of -72.09%. That is a compound annual growth rate of -16.08%.

Market Cap History

Date	Market Cap	% Change
Feb 13, 2026	18.03M	-30.08%
Dec 31, 2025	25.78M	-27.58%
Dec 31, 2024	35.60M	129.87%
Dec 29, 2023	15.49M	-71.47%
Dec 30, 2022	54.30M	-87.89%
Dec 31, 2021	448.32M	27.67%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Nov 6, 2018	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
AstraZeneca	234.47B
GSK plc	85.92B
Haleon	36.22B
Smith & Nephew	11.26B
Sareum Holdings	25.54M
Aptamer Group	23.60M
Palatin Technologies	20.20M
Fusion Antibodies	19.38M

Market Cap Rankings